Back to Journals » Drug, Healthcare and Patient Safety » Volume 3
Perspectives
Should benefit–risk assessment have its own drug “label”?
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,553 | Dovepress* | 8,753+ | 1,833 | 10,586 | |
PubMed Central* | 800 | 156 | 956 | ||
Totals | 9,553 | 1,989 | 11,542 | ||
*Since 3 August 2011 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
7 | 0 | 0 | 0 | 3 | 4 |
View citations on PubMed Central and Google Scholar